$1200 | Single User
$2000 | Global License

Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019)
[Lowest Price Guaranteed: $1,200]

Published by Daedal Research: 01 Aug 2015 | 40651 | In Stock

Introduction

Scope of the Report

The report titled “Global In-Vitro-Fertilization (IVF) Market: Trends and Opportunities (2015-2019)”, analyzes the potential opportunities and significant trends in the global in- vitro-fertilization market. The market size and forecast in value terms and number of IVF cycles for global IVF market has been provided for the period 2010 to 2019, considering 2014 as the base year. The report provides market share analysis of the global IVF market by regions, treatment costs, players and segments. The market is further segment by drug mechanism and different dosage forms.

The report provides detailed country analysis of the IVF markets of Australia, India and the United States. The market size and forecast both in terms of value and volume is covered in the country analysis segment. Also, the various factors driving growth have been analyzed specific to each country.

The report also profiles key market players such as Vitrolife, Monash IVF and OvaScience on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments.

Country Coverage

• United States

• India

• Australia

Company Coverage

• Monash Group

• OvaScience

• Vitrolife


Executive Summary

IVF stands for in-vitro-fertilization and refers to artificial fertilization for people that want to have a baby but are having difficulty getting pregnant.

Rising incidences of infertility as a consequence of increasing maternal age as more women are now starting families later in life is leading to a rise in demand for IVF treatment. Furthermore, lifestyle induced disorders such as obesity and smoking are contributing towards high infertility rates. These together are thus driving the in-vitro fertilization market, as women and their families prefer in-vitro fertilization procedure more compared to the other available procedures. The global in-vitro fertilization market is also witnessing lucrative growth with an increase in medical tourism activities in the developing economies such as India, China and Brazil. The major limiting factor of IVF market is the cost involved in the treatment. Another challenge is the low level of awareness in the developing economies.

The US emerged as the highest revenue contributing regional market for IVF in 2013. The growth of this market in the region is attributed to the presence of large population base suffering from infertility. Moreover, the availability of high disposable income with the people of this region is contributing to the growth of the IVF market. Asia Pacific is expected to grow at a highest CAGR over the forecasted period of 2015-2019 because of the presence of unmet medical needs coupled with favorable government initiatives pertaining to the development of healthcare infrastructure in emerging economies such as India, China and Japan. Australia has the highest market value and number of IVF cycles in the Asia-Pacific region. Furthermore, increasing medical tourism and availability of cost effective medical procedures in India are expected to positively reinforce In-Vitro fertilization market.

Table of Contents
for Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019)

  • 1. Executive Summary

    2. In-Vitro-Fertilization (IVF): An Introduction

    2.1 IVF Treatment Procedure

    2.2 Causes of Infertility

    2.4 Risk Related to IVF Treatment

    2.4.1 Multiple Births

    2.4.2 Premature Delivery and Low Birth Weight

    2.4.3 Ovarian Hyperstimulation Syndrome

    2.4.4 Miscarriage

    2.4.5 Egg-Retrieval Procedure Complications

    2.4.6 Ectopic Pregnancy

    2.4.7 Birth Defects

    2.4.8 Ovarian Cancer

    2.4.9 Stress

    3. In-Vitro-Fertilization (IVF): Global Market Analysis

    3.1 Global IVF Market – Sizing and Growth: Actual & Forecast

    3.2 Global IVF Market Share: An Analysis

    3.2.1 Global IVF Market Share by IVF Cycles per Region

    3.2.2 Global IVF Treatment Cost by Regions

    3.2.3 Global Fertility Rates by Regions

    3.2.4 Global IVF Penetration by Regions

    3.2.5 Global IVF Market by Segments

    3.2.6 Global IVF Market by Key Players

    4. Country Analysis:In-Vitro-Fertilization (IVF) Market

    4.1 Australia IVF Market: An Analysis

    4.1.1 Australia IVF Market: Actual & Forecast

    By Value

    By Number of IVF Cycles

    4.1.2 Australia IVF Market Drivers

    Reproductive Age of Women

    Increasing Penetration (% of women opting for IVF over natural conception)

    Increasing Social Acceptance & Awareness

    Fertility Rate

    Affordability

    4.2 India IVF Market: An Analysis

    4.2.1 India IVF Market: Actual & Forecast

    By Value

    By Number of IVF Cycles

    4.2.2 India IVF Market Drivers

    Increasing Fertility Tourism

    Declining Fertility Rate

    Affordability

    4.3 The US IVF Market: An Analysis

    4.3.1 The US IVF Market: Actual and Forecast

    By Value

    By Number of IVF Procedures

    By Number of Infants Births by Using IVF

    4.3.2 The US IVF Market Breakdown

    By Age Group

    By Number of Embryos Transferred

    4.3.3 The US IVF Market Drivers

    Birth Rates

    Declining Fertility Rates

    Increasing Same Sex Married Couples

    Obesity

    4.3.4 US IVF Industry Landscape and M&A Activity

    5. Market Dynamics: In-Vitro-Fertilization (IVF) Market

    5.1 Growth Drivers

    5.1.1 Decline in Fertility Rates

    5.1.2 Delay in Motherhood

    5.1.3 Rising Healthcare Expenditure

    5.1.4 IVF Success Rates

    5.2 Challenges

    5.2.1 Physical and Emotional Impact

    5.2.2 Legal Issues

    5.2.3 Ethical Issues

    5.2.4 Clinical Issues

    5.2.5 Cost of the Treatment

    5.2.6 Multiple Pregnancies

    5.3 Market Trends

    5.3.1 Medical Tourism

    5.3.2 New Technology Trends

    Robotic Surgery Used in Tubal Reversal

    Transfer of Vitrified Embryos

    Surrogate Alternatives

    5.3.3 Rise in Same Sex Marriages

    6. Competitive Landscape: In-Vitro-Fertilization (IVF) Market

    7. Company Profiles: In-Vitro-Fertilization (IVF) Market

    7.1 Monash

    7.1.1 Business Overview

    7.1.2 Financial Overview

    7.1.3 Business Strategy

    7.2 Vitrolife

    7.2.1 Business Overview

    7.2.2 Financial Overview

    7.2.3 Business Strategy

    7.3 OvaScience

    7.3.1 Business Overview

    7.3.2 Financial Overview

    7.3.3 Business Strategy

    List of Figures and Tables

    Figure 1: IVF Treatment Procedure

    Figure 2: Causes of Infertility; 2013

    Figure 3: Global Rate of Natural Conception by Age Group over a Year (%); 2014

    Figure 4: Global IVF Market by Value; 2012-2014 (US$ Billion)

    Figure 5: Global IVF Market by Value; 2015E-2019E (US$ Billion)

    Figure 6: Global IVF Market Share by IVF Cycles per Regions; 2013

    Figure 7: Global IVF Treatment Costs by Regions; 2014 (US$)

    Figure 8: Global Fertility Rates by Regions; 2014

    Figure 9: Global IVF Penetration (woman undertaking IVF as % of total births); 2013

    Figure 10: Global IVF Market by Segments; 2013

    Figure 11: Global IVF Market by Key Players; 2013

    Figure 13: Australia Number of IVF Cycles per Women; 2009-2014

    Figure 12: Australia Number of Fresh IVF Cycles per Women by Age Group; 2013

    Figure 14: Australia IVF Market Size by Value; 2010-2014 (US$ Million)

    Figure 15: Australia IVF Market Size by Value; 2015E-2019E (US$ Million)

    Figure 16: Australia and New Zealand IVF Market Size by Number of IVF Cycles; 2008-2013

    Figure 17: Australia & New Zealand IVF Market Size by Number of IVF Cycles; 2014E-2019E

    Figure 18: Australia Female Population by Age Group; 2003-2013 (Millions)

    Figure 19: IVF Penetration in Australia; 2002-2013

    Figure 20: Australia Fertility Rates; 2005-2013 (births per women)

    Figure 21: India IVF Market by Value; 2012-2014 (US$ Million)

    Figure 22: India IVF Market by Value; 2015E-2019E (US$ Million)

    Figure 23: India IVF Market by No. of IVF Cycles; 2014-2019E (in 000s)

    Figure 24: India Fertility Rates; 2010-2014 (births per women)

    Figure 25: The US Fertility Treatment Costs; 2014 (US$)

    Figure 26: Cumulative Success Rate of IVF Procedure in the US; 2014

    Figure 27: The US IVF Market by Value; 2010-2014 (US$ Billion)

    Figure 28: The US IVF Market by Value; 2015E-2019E (US$ Billion)

    Figure 29: The US IVF Market Size by Number of IVF Procedures; 2002-2014 (in 000s)

    Figure 30: The US IVF Market Size by Number of IVF Procedures; 2014E-2019E (in 000s)

    Figure 31: The US IVF Market Size by Number of Infants Births by Using IVF; 2002-2014 (in 000s)

    Figure 32: The US IVF Market Size by Number of Infants Births by Using IVF; 2015E-2019E (in 000s)

    Figure 33: Number of IVF Cycles in the US by Age Group; 2013

    Figure 34: Average No. of Embryos Transferred in the US; 2013

    Figure 35: Percentage of Transfers Resulting in Live Births in the US; 2013

    Figure 36: The US Birth Rates by Age of Women; 1990-2013 (%)

    Figure 37: The US Fertility Rates; 2005-2013

    Figure 38: Infertility Rates by Age; 2014

    Figure 39: Same Sex Married Couples in the US; 2008-2013

    Figure 40: Growing Prevalence of Obesity among US Adults; 2012-2030

    Figure 41: Global Fertility Rates; 1960-2015E

    Figure 42: Global Birth Rate per 1000 Women; 1950-2013

    Figure 43: Decline in Male Fertility with Age

    Figure 44: Global Healthcare Expenditure, 2005-2013 (US$ Trillion)

    Figure 45: GDP per Capita, 2003-2013 (US$)

    Figure 46: Success Rates for IVF Treatments; 2013

    Figure 47: The UK Live Birth Rates, 1992-2010

    Figure 48: Monash Net Revenue; 2012-2014 (US$ Million)

    Figure 49: Monash Net Revenue Breakdown; 2012-2014 (US$ Million)

    Figure 50: Number of IVF Cycles vs. Revenue per Cycle; 2012-2016E

    Figure 51: Monash Group Number of PGD/PGS Procedures; 2011-2014

    Figure 52: Vitrolife Net Revenue; 2010-2014 (US$ Million)

    Figure 53: OvaScience Net Revenue; 2015-2020E (US$ Million)

    Table 1: India IVF Market Statistics; 2014 & 2020

    Table 2: Obesity-Related Fertility Issues

    Table 3: M&A Activity in IVF Industry in the US

    Table 4: Comparative Analysis of IVF Industry Players; 2014

Additional Details

Publisher

Daedal Research

Publisher Information

Daedal Research has created a name for itself as one of the leading global knowledge service providers of choice. We offer a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help our clients with perfect answers to their important business queries.



We are a research and consulting firm specialized in providing research reports and customized business research and analysis. Our success parameter is very simple - impact of our services on our clients' business.



Daedal Research is the final destination to all businesses problems covering business intelligence, research and analytics.

Reference

40651 |

Number of Pages

80

Report Format

PDF

Daedal Research Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Physician Views: Post ADA view on key diabetes market developments
ScopeLast week’s American Diabetes Association (ADA) meeting provided further evidence that the diab...
01 Jul 2013 by FirstWord Pharma USD $695 More Info
Physician Views: Key developments in the European diabetes market - will endocrinologists embrace Tresiba and Forxiga? – both rejected by the FDA
ScopeEuropean-based endocrinologists are currently getting to grips with two new products that have ...
01 Jul 2013 by FirstWord Pharma USD $695 More Info
Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class
ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
01 Jun 2013 by FirstWord Pharma USD $695 More Info
Physician Views: Life after Gleevec in the chronic myeloid leukaemia (CML) market?
ScopeNovartis' Gleevec is widely credited as being one of the most important drug launches of all ti...
01 Jun 2013 by FirstWord Pharma USD $695 More Info
Therapy Trends: Alzheimer's Disease - Breaking new ground in disease modification
IntroductionIn 2012, the Alzheimer’s disease (AD) market was dealt a huge blow following negative re...
01 Dec 2012 by FirstWord Pharma USD $7,900 More Info
Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma
IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
01 Jun 2012 by FirstWord Pharma USD $995 More Info
Branded Generics in South East Asia: Current and Future Opportunities
IntroductionWith its fast-growing, young population and projected pharmaceutical sales in excess of ...
01 Apr 2012 by FirstWord Pharma USD $945 More Info
Market Access: Communicating Value Stories to Payers
IntroductionThroughout the EU, reimbursement decisions are increasingly decentralised, making the pr...
01 Apr 2012 by FirstWord Pharma USD $695 More Info
Gauging the Biosimilar Effect: will the market boom or bust?
IntroductionIt was supposed to be the “epoch of biosimilars”, or drugs that copied existing biologic...
01 Jan 2012 by FirstWord Pharma USD $895 More Info
Pricing and Reimbursement Trends in the US: Impact of Comparative Effectiveness Research and Cost-Effectiveness Analysis
IntroductionPublic healthcare costs are rising. Governments need to get them under control. In Europ...
01 Jan 2012 by FirstWord Pharma USD $695 More Info

This report is published by Daedal Research

Daedal Research has created a name for itself as one of the leading global knowledge service providers of choice. We offer a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help our clients with perfect answers to their important business queries.

We are a research and consulting firm specialized in providing research reports and customized business research and analysis. Our success parameter is very simple - impact of our services on our clients' business.

Daedal Research is the final destination to all businesses problems covering business intelligence, research and analytics.

Download Free Report Summary PDF

Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...